Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ambroxol hydrochloride + clenbuterol hydrochloride
- Development stage
- Unknown
- Lead developer
- Hubei Furen Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qiaoruosu is a combination pharmaceutical product containing ambroxol hydrochloride and clenbuterol hydrochloride, developed and manufactured by Hubei Furen Pharmaceutical. It is formulated as an oral solution primarily indicated for the treatment of respiratory disorders associated with bronchospasm and abnormal mucus secretion, such as chronic bronchitis, bronchial asthma, and emphysema. Ambroxol hydrochloride acts as a mucolytic and secretolytic agent, reducing the viscosity of phlegm and promoting its clearance by stimulating surfactant production and ciliary activity. Clenbuterol hydrochloride is a potent beta-2 adrenergic receptor agonist that induces bronchodilation by relaxing airway smooth muscle. Together, these components alleviate coughing, facilitate expectoration, and improve airflow in patients with obstructive airway diseases.
- Brand names
- Qiaoruosu
- Other names
- Ambroxol and Clenbuterol Oral Solution氨溴特罗口服溶液
02
Targets
SCN5A (Sodium channel protein type 5 subunit alpha)ADRB2 (β2)
Beyond the preview
Go deeper on ambroxol hydrochloride + clenbuterol hydrochloride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ambroxol hydrochloride + clenbuterol hydrochloride.